Woodline Partners LP Adicet Bio, Inc. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.21 - $2.4 $301,290 - $597,600
-249,000 Reduced 33.87%
486,095 $588,000
Q1 2024

May 15, 2024
BUY
$1.76 - $3.45 $1.29 Million - $2.54 Million
735,095 New
735,095 $1.73 Million
Q2 2022

Aug 15, 2022
SELL
$10.26 - $20.81 $2.02 Million - $4.09 Million
-196,504 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$11.53 - $19.97 $2.27 Million - $3.92 Million
196,504 New
196,504 $3.92 Million

Others Institutions Holding ACET

# of Institutions
72
Shares Held
59.2M
Call Options Held
4.2K
Put Options Held
6.7K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $39.6M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email